Mi Na Kim

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Topics

Patients Undergoing

Chronic Kidney Disease

Liver Metastases

Hepatitis B Virus

Top Venues

International journal of cancer

Journal of viral hepatitis

Journal of gastroenterology and hepatology

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Jae Seung Lee, Hye-Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung-Up Kim
Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center. Journal of gastroenterology and hepatology (2024)
Mi Na Kim, Xuehong Zhang, Sang Hoon Ahn
Reply to: Comments on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients". International journal of cancer (2024)
Jae Seung Lee, Hye-Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung-Up Kim
Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center. Journal of gastroenterology and hepatology 39 (6) (2024)
Mi Na Kim, Xuehong Zhang, Sang Hoon Ahn
Reply to: Comments on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients". International journal of cancer 154 (7) (2024)
Jae Seung Lee, Hye-Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung-Up Kim
Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center. Journal of gastroenterology and hepatology 39 (6) (2024)
Mi Na Kim, Xuehong Zhang, Sang Hoon Ahn
Reply to: Comments on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients". International journal of cancer 154 (7) (2024)
Mi Na Kim, Kyungdo Han, Juhwan Yoo, Seong Gyu Hwang, Xuehong Zhang, Sang Hoon Ahn
Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients. International journal of cancer (2023)
Mi Na Kim, Sang Hoon Ahn
Editorial: concurrent fatty liver and chronic viral hepatitis: a dual calamity leading to increased risk of hepatocellular carcinoma? Authors' reply. Alimentary pharmacology & therapeutics 55 (4) (2022)
Young Eun Chon, Soo Young Park, Seung-Up Kim, Han Pyo Hong, Jae Seung Lee, Hye-Won Lee, Mi Na Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study. Journal of viral hepatitis 29 (4) (2022)
Mi Na Kim, Kyungdo Han, Juhwan Yoo, Yeonjung Ha, Young Eun Chon, Ju Ho Lee, Seong Gyu Hwang
Changes in general and central fatness are associated with hepatocellular carcinoma: A Korean nationwide longitudinal study. International journal of cancer 150 (10) (2022)
Jae Seung Lee, Young Eun Chon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Won Seok Kang, Moon Seok Choi, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung-Woon Paik, Hwi Young Kim, Tae Hun Kim, Hyuck Sun Kwon, Yeonjung Ha, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang, Soon Sun Kim, Hyo-Jung Cho, Jae-Youn Cheong, Sung Won Cho, Seung Ha Park, Nae-Yun Heo, Young Mi Hong, Ki Tae Yoon, Mong Cho, Jung Gil Park, Min-Kyu Kang, Soo-Young Park, Young Oh Kweon, Won Young Tak, Se Young Jang, Dong Hyun Sinn, Seung-Up Kim, null null
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma. Yonsei medical journal 62 (1) (2021)
Mi Na Kim, Kyungdo Han, Juhwan Yoo, Seong Gyu Hwang, Sang Hoon Ahn
Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver. Alimentary pharmacology & therapeutics (2021)
Young Eun Chon, Kyu Sik Jung, Yeonjung Ha, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang, Sang Hoon Ahn, Do Young Kim, Kwang-Hyub Han, Jun Yong Park
High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosis. Journal of viral hepatitis 27 (11) (2020)
Seung-Up Kim, Yong Eun Chon, Yeon Seok Seo, Hye-Won Lee, Han Ah Lee, Mi Na Kim, In Kyung Min, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Beom Kyung Kim, Soo Young Park
A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy. Journal of viral hepatitis 27 (12) (2020)
Jin Won Chang, Jae Seung Lee, Hye-Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Yu Rim Lee, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Soo Young Park, Seung-Up Kim
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir. Journal of viral hepatitis 28 (1) (2020)
Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Kwang-Hyub Han, Do Young Kim
Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis. Scandinavian journal of gastroenterology 54 (10) (2019)
Mi Na Kim, Seung Min Lee, Jin Sung Kim, Seong Gyu Hwang
Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma. Cancer chemotherapy and pharmacology 84 (4) (2019)
Mi Na Kim, Seong Gyu Hwang, Kyu Sung Rim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung-Up Kim
Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir. Liver international : official journal of the International Association for the Study of the Liver 37 (12) (2017)
Mi Na Kim, Hyon-Suk Kim, Ja Kyung Kim, Beom Kyung Kim, Seung-Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han
Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C. Journal of Korean medical science 31 (9) (2017)